Area of research
Molecular Biology · Hematology
Research interest
Research focused on Bromodomain and Epigenetics, with related work in Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), Kinase, Computational biology. Notable publications include 'Dual kinase-bromodomain inhibitors for rationally designed polypharmacology', 'CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses', and 'PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains'.
Discovery of a Potent, Selective, and Cell-Active SPIN1 Inhibitor
Open science discovery of potent noncovalent SARS-CoV-2 main protease inhibitors
Identification of a small-molecule ligand of the epigenetic reader protein Spindlin1 via a versatile screening platform
CBP30, a selective CBP/p300 bromodomain inhibitor, suppresses human Th17 responses
Dual kinase-bromodomain inhibitors for rationally designed polypharmacology
PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains